Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0900
+0.0100 (12.50%)
Jun 12, 2024, 11:19 AM EDT - Market open

Nascent Biotech Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Year Current20222021202020192018 2017 - 2012
Market Capitalization
1576495
Upgrade
Market Cap Growth
-8.60%36.92%-51.34%71.13%-16.76%
Upgrade
Enterprise Value
1576595
Upgrade
PE Ratio
-35.19-2.38-41.58-3.41-2.25-3.93
Upgrade
PS Ratio
--6.145.98--
Upgrade
PB Ratio
503.04-5.15-9.15-9.49-3.21-11.17
Upgrade
P/FCF Ratio
-23.68-3.7314.85-4.55-16.63-7.57
Upgrade
P/OCF Ratio
-23.68-3.7314.85-4.55-16.63-7.57
Upgrade
EV/Sales Ratio
--6.056.19--
Upgrade
EV/EBITDA Ratio
-12.61-3.19-9.94-3.27-2.71-3.84
Upgrade
EV/EBIT Ratio
-9.91-1.97----
Upgrade
EV/FCF Ratio
-23.28-3.8514.62-4.71-16.87-7.38
Upgrade
Debt / Equity Ratio
4.12-0.300-0.34-0.050
Upgrade
Debt / EBITDA Ratio
-0.06-0.18--0.11-0.04-
Upgrade
Debt / FCF Ratio
-0.10-0.22--0.16-0.25-
Upgrade
Quick Ratio
1.020.110.120.610.000.21
Upgrade
Current Ratio
1.050.160.140.610.000.21
Upgrade
Asset Turnover
009.491.0000
Upgrade
Interest Coverage
-14.64-1.25-1.36-4.16-39.790
Upgrade
Return on Equity (ROE)
-6892.89%216.10%22.00%278.26%142.25%283.91%
Upgrade
Return on Assets (ROA)
-326.40%-1098.41%-140.12%-174.97%-127121.78%-1041.22%
Upgrade
Return on Capital (ROIC)
-1450.55%237.80%68.07%450.61%125.96%283.92%
Upgrade
Earnings Yield
-13.70%-42.00%-2.41%-29.31%-44.38%-25.42%
Upgrade
FCF Yield
-7.99%-26.80%6.73%-22.00%-6.01%-13.22%
Upgrade
Buyback Yield / Dilution
-39.95%-10.05%-48.93%-110.34%-14.30%-16.25%
Upgrade
Total Shareholder Return
-39.95%-10.05%-48.93%-110.34%-14.30%-16.25%
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.